SCHEMBL6844907

SCHEMBL6844907

Cc1c(-c2ccoc2)ccc(CS(=O)(=O)c2ccccc2)c1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.39
NAT1 P18440 3/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ALOX5 P09917 1/20 0.34
HSD11B1 P28845 3/20 0.33
MMP2 P08253 1/20 0.33
MMP13 P45452 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ESR1 P03372 1/20 0.33
POLB P06746 1/20 0.33
NR4A1 P22736 1/20 0.33
APEX1 P27695 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6844888 0.89 NAT1 (0.40) METAP2NAT1MEN1KMT2AMMP2
SCHEMBL1648400 0.87 METAP2 (0.39) METAP2NAT1PTGDR2TSHRHSD17B10
SCHEMBL1648039 0.87 NAT1 (0.39) METAP2NAT1TSHRHSD17B10MEN1
SCHEMBL1648688 0.86 NAT1 (0.38) METAP2NAT1TSHRHSD17B10NPC1
SCHEMBL1647756 0.85 METAP2 (0.53) METAP2NAT1KMT2ANPC1RAB9A
SCHEMBL1648374 0.85 METAP2 (0.40) METAP2NAT1PTGDR2TSHRHSD17B10
SCHEMBL1648358 0.84 METAP2 (0.37) METAP2NAT1PTGDR2TSHRHSD17B10
SCHEMBL14725681 0.84 NAT1 (0.35) METAP2NAT1PTGDR2TSHRHSD17B10
SCHEMBL1648269 0.84 METAP2 (0.43) METAP2NAT1MEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL1648037 0.83 NAT1 (0.34) METAP2NAT1PTGDR2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same ZAFGEN, INC. 2013-02-28 US disclosed
WO-2011044506-A2 SULPHONE COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN CORPORATION (US) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same METAP2, DNPEP, STS METAP2 1/4885NAT1 136/4885PTGDR2 2007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.